Adelene Q. Perkins, EVP and Chief Business Officer at INFINITY PHARMACEUTICALS, INC. (INFI), bought 12,648 shares at $11.03 ($140K) on 2007-05-04, disclosed to the SEC on 2007-05-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.24 | 700 | $8K | 5.6% |
| 2 | $11.25 | 200 | $2K | 1.6% |
| 3 | $10.99 | 500 | $5K | 3.9% |
| 4 | $11.00 | 1,200 | $13K | 9.5% |
| 5 | $11.00 | 1,000 | $11K | 7.9% |
| 6 | $11.00 | 108 |
| $1K |
| 0.9% |
| 7 | $11.03 | 1,000 | $11K | 7.9% |
| 8 | $11.04 | 240 | $3K | 1.9% |
| 9 | $11.04 | 100 | $1K | 0.8% |
| 10 | $11.05 | 1,000 | $11K | 7.9% |
| 11 | $11.15 | 1,000 | $11K | 8.0% |
| 12 | $11.20 | 600 | $7K | 4.8% |
| 13 | $11.20 | 1,000 | $11K | 8.0% |
| 14 | $11.23 | 500 | $6K | 4.0% |
| 15 | $10.88 | 1,000 | $11K | 7.8% |
| 16 | $10.88 | 500 | $5K | 3.9% |
| 17 | $10.90 | 100 | $1K | 0.8% |
| 18 | $10.90 | 800 | $9K | 6.2% |
| 19 | $10.90 | 900 | $10K | 7.0% |
| 20 | $10.90 | 200 | $2K | 1.6% |
| Total | $11.04 avg | 12,648 | $140K | 100% |
| Filing → |
| INFI | SELL | 2018-03-07 | $14K | — | Filing → |
| INFI | SELL | 2015-06-26 | $55K | — | Filing → |
| INFI | SELL | 2015-05-28 | $128K | — | Filing → |